ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ILSE Intralase Corp (MM)

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Intralase Corp (MM) NASDAQ:ILSE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Dr. James J. Salz of the Laser Eye Associates of Los Angeles Contributes to Milestone One Millionth Blade-Free LASIK Procedures

09/11/2006 10:07pm

PR Newswire (US)


Intralase (NASDAQ:ILSE)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Intralase Charts.
Dr. Salz Is the First Surgeon in Los Angeles, and One of the First Nationwide, to Offer Blade-Free LASIK With the IntraLase Method LOS ANGELES, Nov. 9 /PRNewswire-FirstCall/ -- Dr. James J. Salz of the Laser Eye Associates of Los Angeles is among a select number of ophthalmic surgeons whose work has contributed toward the milestone one millionth all-laser LASIK procedure using the IntraLase Method(TM), confirming the demand for IntraLase(R) FS laser technology, according to IntraLase Corp. (NASDAQ:ILSE). Dr. Salz was the first surgeon in Los Angeles, and one of the first in the entire country, to offer blade-free LASIK with the IntraLase Method. The IntraLase FS laser is the first technology for a truly all-laser, blade-free LASIK procedure, replacing the hand-held microkeratome blade historically used in creating LASIK corneal flaps -- the first step of the procedure -- with a computer-guided, ultra-fast femtosecond (fem-to-second) laser. The IntraLase laser virtually eliminates the most severe sight- threatening LASIK complications related to use of the microkeratome and, by creating an optimal corneal surface below the flap, provides for better visual outcomes -- taking many patients to 20/20 vision and beyond. "We have seen a significant improvement in our visual acuity outcomes and a meaningful reduction in our LASIK complication rate using the IntraLase Method," said Dr. Salz. "The blade-free approach is a very comforting message to patients, since it addresses one of their primary obstacles -- fear of the surgery. Offering the IntraLase all-laser LASIK platform has been a very positive experience for our patients, referring doctors and surgeons." In addition to the Laser Eye Associates of Los Angeles, the IntraLase FS laser technology has been adopted by such top ophthalmic teaching institutes as Duke University Medical School, the Wilmer Eye Institute at Johns Hopkins, the Bascom Palmer Eye Institute at University of Miami, and Stanford University, all of which use the technology to train future generations of LASIK surgeons. Blade-Free Safety and Better Vision with All-Laser LASIK According to Dr. Salz, the 4th Generation IntraLase FS laser uses an infrared light beam, generating 60,000 pulses per second, to prepare the intracorneal bed and create the corneal flap in the first step of LASIK. * Using an "inside-out" process, the laser beam is precisely focused to a point within the cornea. * The laser pulses then create thousands of microscopic bubbles which define the incision within the intracorneal surface. * Along the edge, bubbles are then stacked up at a beveled angle -- a feature unique to the IntraLase Method -- to the corneal surface to complete the flap. * From start to finish, the IntraLase Method typically takes 15 - 30 seconds. * The physician then exposes the prepared corneal bed for excimer laser treatment (the second step of LASIK) by lifting the flap. * The LASIK procedure is complete when the flap is securely repositioned on its beveled edge. With the IntraLase laser, the surgeon can precisely control the critical first step of LASIK. Physician-programmed laser specifications include flap diameter, depth, hinge location and width, and side-cut architecture -- factors which can be varied to meet patients' needs. The IntraLase laser creates a distinctive beveled-edge flap, which allows for precise repositioning, alignment and seating after LASIK is completed. This feature reduces the risk of flap displacement, a complication seen with microkeratome flaps. "The IntraLase laser makes LASIK safer by replacing the hand-held microkeratome blade with the computer-guided precision of a laser," said Dr. Salz, noting that the completion of approximately one million IntraLase Method procedures demonstrates an impressive safety profile for patients. LASIK with the advanced IntraLase Method, he added, also has been clinically proven to deliver better visual outcomes in both standard and Custom LASIK procedures with more patients achieving visual acuity of 20/20, 20/15 and even 20/12.5. About Dr. James Salz Los Angeles LASIK surgeon Dr. James Salz has more than 22 years experience in corneal refractive surgery. Dr. Salz has been and still is one of the principal investigators for the FDA trials involving the use of laser to correct Nearsightedness (myopia), Farsightedness (hyperopia), and Astigmatism. Patients who have had problems with previous eye surgery frequently consult Dr. Salz. He also often is selected by many other ophthalmologists to perform their eye surgery. About IntraLase Corp. IntraLase designs, develops, and manufactures an ultra-fast laser that is revolutionizing refractive and corneal surgery by creating safe and more precise corneal incisions. Delivering on the promise of ophthalmic laser technology, the IntraLase FS laser, related software, and disposable devices replace the hand-held microkeratome blade used during LASIK surgery. The unsurpassed accuracy of IntraLase's computer-controlled femtosecond laser has been shown to improve safety profiles and visual outcomes when used during LASIK. Additionally, the IntraLase FS laser creates precision-designed intracorneal incisions that when combined can be used during lamellar and penetrating keratoplasty, and intrastromal ring implantation. IntraLase is presently in the process of commercializing applications of its technology in the treatment of corneal diseases that require corneal transplant surgery. The company's proprietary laser and disposable patient interfaces are presently marketed throughout the United States and 32 other countries. IntraLase is headquartered and manufactures its products in Irvine, California. For additional information, visit the company's web site: http://www.intralase.com/. DATASOURCE: IntraLase Corp. CONTACT: Donna Jones of Laser Eye Associates of Los Angeles, +1-310-360-0609 Web site: http://www.intralase.com/

Copyright

1 Year Intralase Chart

1 Year Intralase Chart

1 Month Intralase Chart

1 Month Intralase Chart

Your Recent History

Delayed Upgrade Clock